Intake Breathing Technology v. Joventures — Settled After 127 Days
Intake Breathing Technology, LLC filed suit against Joventures in the Central District of California asserting three patents covering the Intake® Breathing System and Vita O2 product. The infringement action settled within 127 days. Specific settlement terms are not disclosed in the available record.
Three-patent breathing device dispute resolved inside four months
Intake Breathing Technology, LLC filed this patent infringement action on 17 February 2026 in the U.S. District Court for the Central District of California, Case No. 8:26-cv-00352. The complaint asserted three patents — US10556095B2, US9510969B2, and US10675174B2 — against defendant Joventures, with the asserted products identified as the Intake® Breathing System and Vita O2. Plaintiff was represented by Quarles & Brady LLP; no defendant law firm is recorded in the available docket.
The recorded Basis of Termination is 'Case Settled.' The docket order states that the court was advised by counsel for both parties that the action had been settled, and ordered the case dismissed in its entirety without prejudice to reopen within 30 days if settlement is not consummated, with all proceedings vacated and taken off calendar. The specific terms of the settlement are not disclosed in the available record.
Resolution in 127 days is notably swift for a three-patent infringement action and suggests the parties reached commercial agreement well before any substantive motion practice or claim construction proceedings could unfold. What drove the settlement — whether licensing, product design changes, or other commercial terms — is not reflected in the public record.
See Complete Case & Patent Analysis →Filing to Case Settled in 127 days
127 days from filing to close — a relatively rapid resolution for patent infringement litigation
US10556095B2, US9510969B2 & US10675174B2 — Intake® Breathing System patents
Any company developing, manufacturing, or distributing respiratory breathing devices, airflow assist products, or products that functionally overlap with the Intake® Breathing System or Vita O2 category should treat this three-patent portfolio as a live FTO priority. The settlement without merits adjudication means no claim construction, no invalidity ruling, and no infringement finding exists to inform design-around analysis — the risk profile is entirely uncharted by judicial record.
Official order — verbatim text
The docket order records that counsel for both parties advised the court of a settlement, resulting in a dismissal without prejudice with a 30-day window to reopen if consummation fails. The order vacates all pending proceedings. No ruling on infringement, validity, or damages was issued, leaving the substantive merits of all three asserted patents entirely unresolved by the court.
Case settled: what the agreed resolution means for both parties
Settlement with court-ordered dismissal without prejudice
Counsel for both parties advised the court that the action had been settled. The court ordered the case dismissed in its entirety without prejudice, preserving the right to reopen within 30 days if settlement is not consummated. All proceedings were vacated and taken off calendar. The specific terms of the underlying agreement are not disclosed in the available record.
Settlement — terms undisclosedIntake Breathing Technology secures early resolution of its patent claims
As plaintiff, Intake Breathing Technology asserted three patents against Joventures and reached a settlement before any substantive court rulings on validity or infringement. The without-prejudice dismissal structure preserves the right to reopen if the settlement is not finalised within 30 days. The commercial terms — including any licensing or royalty arrangement — are not disclosed in the available record.
Early resolutionJoventures avoids adjudicated infringement finding
Joventures resolved the three-patent infringement action without any court ruling on the merits of infringement or validity. The case ending in settlement means no adverse judgment was entered against the defendant. The specific obligations, if any, that Joventures accepted as part of the settlement are not disclosed in the available record.
No merits adjudicationBreathing device IP enforcement risk remains live for the sector
The settlement without prejudice leaves Intake Breathing Technology's three patents fully enforceable. Competitors and product developers in the respiratory and breathing device space should note that all three asserted patents remain active and unchallenged on the merits. Companies with products adjacent to the Intake® Breathing System or Vita O2 category should monitor this patent family for future enforcement activity.
Patents remain enforceableFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Intake Breathing Technology, LLC | Company | /Search in Eureka ↗ |
| Defendant | Joventures | Individual | /Search in Eureka ↗ |
| Plaintiff counsel | Aaron J Schu | Attorney | Counsel for Intake Breathing Technology, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Christina R. Snider | Attorney | Counsel for Intake Breathing Technology, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Dawn M. David | Attorney | Counsel for Intake Breathing Technology, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Quarles & Brady LLP | Law Firm | Representing Intake Breathing Technology, LLCSearch in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | California Central District CourtSearch in Eureka ↗ |
R&D signals in the breathing device and respiratory IP space
Forward-looking patent and innovation intelligence derived from the Intake Breathing Technology v. Joventures dispute and the broader Intake® Breathing System portfolio.
Intake Breathing Technology's multi-patent enforcement portfolio
Intake Breathing Technology has assembled at least three granted US patents across staggered application filings (US14/628517, US14/799192, US15/016087), suggesting a deliberate continuation or divisional filing strategy to extend claim coverage over the Intake® Breathing System technology. Monitoring this assignee's further prosecution and new filings is advisable for competitors in the respiratory device space.
Active portfolio — 3 patentsFiling trends in breathing assist and airflow device patents
The respiratory and breathing assist device segment has seen sustained patent activity as consumer health and sports performance breathing products expand. The asserted patents' application dates span multiple years, reflecting an evolving claim landscape. Companies active in nasal breathing, airflow optimisation, or wearable respiratory devices should map the current filing density in this space to identify crowded claim clusters and white space.
Respiratory device filing trendsJoventures' Vita O2 and its patent exposure in the breathing device market
Joventures' Vita O2 product was specifically identified as an accused product in this three-patent action. Understanding whether Joventures holds defensive IP of its own in the breathing device space — or whether it operates without a patent portfolio — is material intelligence for assessing competitive dynamics and future litigation risk in this product category.
Defensive IP assessmentAdjacent R&D opportunities beyond the Intake® Breathing System claims
With three patents covering the Intake® Breathing System's core technology, adjacent areas — such as smart sensor-integrated respiratory monitoring, alternative airflow pathway materials, or digital health connectivity for breathing devices — may represent white space where new IP can be developed without entering the existing claim footprint. A freedom-to-operate and white-space analysis around these patents could surface near-term R&D opportunities.
Innovation white spaceSimilar respiratory device patent infringement cases in federal district courts
Explore comparable breathing device and respiratory technology patent infringement actions filed in the Central District of California and related federal courts.
What this case signals for the breathing device IP landscape
A three-patent settlement in under four months highlights the enforcement posture of Intake Breathing Technology and the litigation risk surrounding respiratory device IP.
Swift settlement signals strong plaintiff negotiating position
Resolving a three-patent infringement action in 127 days — before claim construction or any dispositive motions — typically suggests the defendant perceived meaningful litigation risk or commercial value in early resolution. For companies operating near this technology space, this pattern signals an active and efficient enforcement strategy by the patent holder.
All three asserted patents survive unchallenged on the merits
Because the case settled before any validity or infringement rulings, US10556095B2, US9510969B2, and US10675174B2 remain fully enforceable with no adverse judicial record. Product developers and competitors in the breathing device sector cannot rely on any court finding to design around or challenge these patents based on this litigation.
Intake v Joventures — key questions answered
Intake Breathing Technology asserted three patents: US10556095B2 (application no. US14/799192), US9510969B2 (application no. US14/628517), and US10675174B2 (application no. US15/016087). All three relate to breathing system technology. The accused products were identified as the Intake® Breathing System and Vita O2.
The recorded Basis of Termination is 'Case Settled.' The court was advised by counsel that the action had been settled and ordered dismissal without prejudice, with a 30-day window to reopen if the settlement is not consummated. All proceedings were vacated. The specific terms of the settlement are not disclosed in the available record.
No. The case settled before any court ruling on validity, infringement, or damages. There is no judicial record finding US10556095B2, US9510969B2, or US10675174B2 either valid or invalid, or Joventures either infringing or non-infringing. All three patents remain enforceable with no adverse ruling on the merits.
The court's order reflects standard practice when counsel advise of a settlement that has not yet been fully consummated. A dismissal without prejudice with a 30-day reopening window protects both parties in the event the settlement agreement is not finalised. Once consummated, the case would be considered fully resolved. The specific consummation status is not reflected in the available public record beyond the order itself.
The settlement without any merits adjudication leaves all three asserted patents — US10556095B2, US9510969B2, and US10675174B2 — fully enforceable and unchallenged by judicial record. Companies developing or selling products in the respiratory breathing device space should consider a freedom-to-operate analysis against this patent family, particularly given the rapid enforcement timeline demonstrated in this case.
This page is compiled from public court dockets and third-party patent and litigation data via PatSnap Eureka, and is provided for general informational purposes only. The information shown — including party names, patent and application numbers, dates, case status, outcomes, and any analysis — may be incomplete, may not reflect the most recent filings or legal status, and may contain errors or omissions. Verify all details against official court records (for example, PACER) and the relevant patent office before relying on them.
Nothing on this page constitutes legal advice or a legal opinion on the validity, infringement, enforceability, or scope of any patent or case, and no attorney‑client relationship is created by its use. Any description of an outcome (such as a dismissal, settlement, or consent judgment) is a general summary, not a legal determination. All patents, trademarks, and company or law‑firm names are the property of their respective owners. PatSnap makes no warranty as to the accuracy or completeness of this content and disclaims, to the fullest extent permitted by law, all liability for reliance on it. For advice on a specific matter, consult qualified legal counsel.
PatSnap Eureka searches patents and litigation data to answer instantly.